As of 2026-06-12, the Fair Value of Mayne Pharma Group Ltd (MYX.AX) is -5.12 AUD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.46 AUD, the upside of Mayne Pharma Group Ltd is -308.21%.
With the market price of 2.46 AUD and our fair value calculation, Mayne Pharma Group Ltd (MYX.AX) is not a good investment. Investing in MYX.AX stocks now will result in a potential loss of 308.21%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 5Y Avg | |
| Net income | -208.42 | -281.29 | 117.25 | -174.23 | -93.84 | -128.11 |
| YoY growth | -124.62% | -34.96% | 141.68% | -248.60% | 46.14% | -44.07% |
| Market Cap (mil) | 199.87 |
| P/E | |
| Forward P/E |
| EPS | -1.02 |
| Avg earnings growth rate | -44.07% |
| TTM earnings | -83.23 |